معرفی
Marta Baro is an Associate Research Scientist in the Department of Therapeutic Radiology at Yale School of Medicine, Yale University. She holds a PhD from the University of Barcelona (2013) and specializes in molecular mechanisms underlying cancer therapy, particularly focusing on radiosensitivity, protein glycosylation, and therapeutic resistance. Her work integrates genetic screening, CRISPR technology, and preclinical models to identify novel targets for enhancing cancer treatment efficacy.
Her research interests center on understanding how protein modifications (e.g., N-glycosylation) and signaling pathways (e.g., NF-κB, STING) influence cancer cell survival and response to therapies. Key projects include targeting the oligosaccharyltransferase complex to overcome EGFR inhibitor resistance and leveraging PLK4 inhibition to radiosensitize lung cancer cells.
Baro collaborates extensively with faculty such as Joseph Contessa and Barbara Burtness, producing over 15 peer-reviewed publications. Her studies span from basic molecular biology to translational oncology, with a focus on improving radiation therapy outcomes through combination strategies. She maintains an active research program in Yale’s Radiobiology division, contributing to interdisciplinary efforts in precision oncology.